- Home
- SOS vs ALZN Comparison
SOS vs ALZN Comparison
Compare SOS & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOS
- ALZN
- Stock Information
- Founded
- SOS 2004
- ALZN 2016
- Country
- SOS China
- ALZN United States
- Employees
- SOS N/A
- ALZN N/A
- Industry
- SOS Finance: Consumer Services
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- SOS Finance
- ALZN Health Care
- Exchange
- SOS Nasdaq
- ALZN Nasdaq
- Market Cap
- SOS 10.7M
- ALZN 9.0M
- IPO Year
- SOS 2017
- ALZN 2021
- Fundamental
- Price
- SOS $1.21
- ALZN $2.05
- Analyst Decision
- SOS
- ALZN Strong Buy
- Analyst Count
- SOS 0
- ALZN 1
- Target Price
- SOS N/A
- ALZN $42.00
- AVG Volume (30 Days)
- SOS 44.4K
- ALZN 137.1K
- Earning Date
- SOS 09-26-2025
- ALZN 12-11-2025
- Dividend Yield
- SOS N/A
- ALZN N/A
- EPS Growth
- SOS N/A
- ALZN N/A
- EPS
- SOS N/A
- ALZN N/A
- Revenue
- SOS $260,505,000.00
- ALZN N/A
- Revenue This Year
- SOS N/A
- ALZN N/A
- Revenue Next Year
- SOS N/A
- ALZN N/A
- P/E Ratio
- SOS N/A
- ALZN N/A
- Revenue Growth
- SOS 134.43
- ALZN N/A
- 52 Week Low
- SOS $1.02
- ALZN $1.89
- 52 Week High
- SOS $15.51
- ALZN $12.24
- Technical
- Relative Strength Index (RSI)
- SOS 34.62
- ALZN 38.81
- Support Level
- SOS $1.11
- ALZN $2.21
- Resistance Level
- SOS $1.40
- ALZN $2.56
- Average True Range (ATR)
- SOS 0.15
- ALZN 0.17
- MACD
- SOS -0.02
- ALZN -0.05
- Stochastic Oscillator
- SOS 21.76
- ALZN 26.03
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.